These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10982207)

  • 41. Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany.
    Strzelczyk A; Bergmann A; Biermann V; Braune S; Dieterle L; Forth B; Kortland LM; Lang M; Peckmann T; Schöffski O; Sigel KO; Rosenow F
    Epilepsy Behav; 2016 Nov; 64(Pt A):75-82. PubMed ID: 27732920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction in Costs after Treating Comorbid Panic Disorder with Agoraphobia and Generalized Anxiety Disorder.
    Ikic V; Belanger C; Bouchard S; Gosselin P; Langlois F; Labrecque J; Dugas MJ; Marchand A
    J Ment Health Policy Econ; 2017 Mar; 20(1):11-20. PubMed ID: 28418834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of comorbidity on the treatment of panic disorder.
    Lecrubier Y
    J Clin Psychiatry; 1998; 59 Suppl 8():11-4; discussion 15-6. PubMed ID: 9707157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study.
    Nsengiyumva G; Druet-Cabanac M; Nzisabira L; Preux PM; Vergnenègre A
    Epilepsia; 2004 Jun; 45(6):673-7. PubMed ID: 15144433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Healthcare utilization and costs in children with stable and uncontrolled epilepsy.
    Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
    Epilepsy Behav; 2014 Mar; 32():135-41. PubMed ID: 24561658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy.
    Ettinger AB; Manjunath R; Candrilli SD; Davis KL
    Epilepsy Behav; 2009 Feb; 14(2):324-9. PubMed ID: 19028602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The costs of epilepsy in Germany].
    Dodel R; Rosenow F; Hamer HM
    Pharm Unserer Zeit; 2007; 36(4):298-305. PubMed ID: 17623320
    [No Abstract]   [Full Text] [Related]  

  • 48. [Epidemiology of panic].
    Batelaan NM; De Graaf R; Van Balkom AJ; Vollebergh WA; Beekman AT
    Tijdschr Psychiatr; 2006; 48(3):195-205. PubMed ID: 16956083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL; Candrilli SD; Edin HM
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intractable epilepsy and patterns of psychiatric comorbidity.
    Hermann BP; Jones JE
    Adv Neurol; 2006; 97():367-74. PubMed ID: 16383147
    [No Abstract]   [Full Text] [Related]  

  • 51. Economic burden of epilepsy in India.
    Thomas SV; Sarma PS; Alexander M; Pandit L; Shekhar L; Trivedi C; Vengamma B
    Epilepsia; 2001 Aug; 42(8):1052-60. PubMed ID: 11554893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Panic disorder and alcoholism: effects of comorbidity].
    Chignon JM; Lépine JP
    Can J Psychiatry; 1993 Sep; 38(7):485-93. PubMed ID: 8242521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gender differences in panic disorder: findings from the National Comorbidity Survey.
    Sheikh JI; Leskin GA; Klein DF
    Am J Psychiatry; 2002 Jan; 159(1):55-8. PubMed ID: 11772690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epileptic seizures and epilepsy in the elderly].
    Krämer G
    Ther Umsch; 2001 Nov; 58(11):684-90. PubMed ID: 11817164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of 'social determinants of health' on epilepsy prevalence and reported medication use.
    Elliott JO; Lu B; Shneker BF; Moore JL; McAuley JW
    Epilepsy Res; 2009 Apr; 84(2-3):135-45. PubMed ID: 19233619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder.
    Frank E; Cyranowski JM; Rucci P; Shear MK; Fagiolini A; Thase ME; Cassano GB; Grochocinski VJ; Kostelnik B; Kupfer DJ
    Arch Gen Psychiatry; 2002 Oct; 59(10):905-11. PubMed ID: 12365877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practical approaches to the treatment of panic disorder.
    J Clin Psychiatry; 1996 Jan; 57(1):45-52. PubMed ID: 8543553
    [No Abstract]   [Full Text] [Related]  

  • 58. [Economic aspects of drug-resistant epilepsy].
    Owczarek K; Jedrzejczak J
    Neurol Neurochir Pol; 2001; 35(2):309-18. PubMed ID: 11599228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treating epilepsy in the elderly: safety considerations.
    Arroyo S; Kramer G
    Drug Saf; 2001; 24(13):991-1015. PubMed ID: 11735655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comorbidity rates do not support distinction between panic disorder and generalized anxiety disorder.
    Starcevic V; Fallon S; Uhlenhuth EH; Pathak D
    Psychopathology; 1994; 27(6):269-72. PubMed ID: 7846249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.